Ionis Pharmaceuticals, Inc. (IONS)

29.06 +1.75 (+6.41%) USD  |  NASDAQ  |  Nov 13, 16:00
28.90 -0.16 (-0.55%) After-Hours: 19:59
More

Ionis Pharmaceuticals Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for IONS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Quarterly Actual Revenue Data

View and export this data back to 2024. Start Trial.
Date Value
September 30, 2026 --
June 30, 2026 --
March 31, 2026 --
December 31, 2025 --
Date Value
September 30, 2025 --
June 30, 2025 --
March 31, 2025 --
December 31, 2024 --

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
Alnylam Pharmaceuticals, Inc. Upgrade
Arrowhead Pharmaceuticals, Inc. Upgrade
BridgeBio Pharma, Inc. Upgrade
Biogen, Inc. Upgrade
TG Therapeutics, Inc. Upgrade